Concomitantly, CML diminishes ATP-binding cassette transporter A1 (ABCA1)-mediated cholesterol efflux, collectively driving lipid accumulation within HK-2 cells. The gene discussed is ABCA1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.